Panacea Biotec Share Price Surges on UNICEF Vaccine Contract Upgrade: News, Forecasts and Stock Analysis for 26 December 2025
Panacea Biotec shares surged on December 26 after the company announced UNICEF had increased its vaccine supply contract by $8.93 million for 2026–27. The stock traded as high as ₹419.40, with midday volume near 13 million shares, following the exchange disclosure of higher contracted values for its Easyfive‑TT vaccine. Indian benchmarks remained subdued in thin holiday trading.
